EMED HEALTHCARE GROUP HOLDINGS, LIMITED

• ⚠

  Material uncertainty over going concern

  The Group remains dependent on the ongoing financial support of its US parent and the successful delivery of the Group's strategic plans.

• ◆

  1 PSC ceased in last 24 months

  Significant control changed hands — see the Ownership section.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

Ecovis Wingrave Yeats LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Group remains dependent on the ongoing financial support of its US parent and the successful delivery of the Group's strategic plans.”

Group structure

1. EMED HEALTHCARE GROUP HOLDINGS, LIMITED · parent
   1. eMed Healthcare UK Limited 100% · United Kingdom · developing and maintaining the Group's products including its technology platform and interfaces. The Company also operates the Group's pharmacy and head office operations
   2. SheMed Limited 100% · United Kingdom · dormant
   3. Babylon Healthcare Services Limited 100% · United Kingdom · provision of healthcare services through NHS contracts, agreements with private insurers, corporate employee benefit arrangements, and services to private patients
   4. eMed Healthcare Services UK Limited 100% · United Kingdom · dormant

Significant events

• “On 25 July 2025, the immediate parent undertaking of the Group, changed from eMed LLC to eMed Population Health Inc, both of which are under common control. The transfer was effected by way of a sale of all shares in eMed Healthcare Group Holdings Limited for nominal consideration of $135.25 (equivalent to £100).”
• “On 28th February 2025, the Group completed an internal restructuring whereby it transferred its entire shareholding in SheMed Limited (a UK subsidiary) to SheMed LLC (a Delaware, US group company), both of which are under common control.”
• “On 3 January 2025, eMed Healthcare UK Limited and Babylon Healthcare Services Limited (both subsidiaries of the Group) entered into a Master Services Agreement with SheMed Limited (also a subsidiary of the Group until its transfer post year-end).”
• “In January 2025, the Group's contract with its largest private insurer customer, BUPA, was terminated. In addition, the Group sub-contracted the servicing of certain private contracts to a third-party.”
• “In October 2025, the Company adopted a resolution to redefine the Group's fiscal year to commence on 1 February of each year and end on 31 January of the following year.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.